Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 443-447
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.443
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.443
Location | Donor | Interval (d) initial | Recipient | Outcome | ||||
(ref. NO.) | Age (yr) | Liver disease | Cause of death | to final transplant | Age (yr) | Liver disease | Early after second transplantation | Long-term |
London, Canada (current report) | 55 | HCV | CVA | 14 | 54 | HCV/HCC | No complications | Died of recurrent HCC at 16 mo |
Madrid, Spain[1,2] | 57 | PBC | CVA | 1 | 29 | CR post LTx for PSC and CCC | No complication | Died of recurrent CCC at 48 mo |
Madrid, Spain[2] | 54 | PSC | CVA | 2 | 32 | CR post LTx for HCV | Sepsis | Died at 4 mo |
Madrid, Spain[2] | 51 | CR post LTx (cause N/A) | CVA | 2 | 56 | HCV/HCC | AR | Alive at 25 mo |
Creteil, France[3] | 24 | CR post LTx for cryptogenic cirrhosis | CVA | 5 | 52 | Alcoholic | AR | Alive at 6 mo |
Essen, Germany[4] | N/A | Cryptogenic cirrhosis | CVA | 1 | 46 | Recurrent HBV post LTx | AR | Alive at 5 mo |
Barcelona, Spain[5] | 55 | Alcoholic | CVA | 5 | 58 | HCV | No complication | Alive at 14 mo |
Brussels, Belgium[6] | 47 | ALF (acetaminophen) | Cerebral edema | 2 | 53 | HCV/HCC | AR | Alive at 22 mo |
Lille Cedex, France[7] | 21 | ALF (acetaminophen) | Cerebral edema | 2 | 61 | HCV | No complication | Alive at 11 mo |
UNOS #1[8] | 6 | N/A | N/A | 1 | N/A | N/A | N/A | Alive at 111 mo |
UNOS #2[8] | 60 | Cryptogenic cirrhosis | CVA | 8 | 44 | N/A | N/A | Alive at 62 mo |
UNOS #3[8] | 21 | N/A | N/A | 1 | N/A | N/A | N/A | Alive at 3.5 mo |
UNOS #4[8] | 49 | N/A | N/A | 4.9 yr | N/A | N/A | failed at 0.1 mo (cause N/A) | - |
UNOS #5[8] | 48 | N/A | N/A | 5 | N/A | N/A | N/A | Failed at 11 mo |
UNOS #6[8] | 56 | HCV | Anoxic brain injury | 2 | N/A | HCV, alcoholic | No complication | Alive at 25.4 mo |
UNOS #7[8] | 49 | N/A | N/A | 6 | N/A | N/A | N/A | Alive at 4.8 mo |
UNOS #8[8] | 35 | ALF (acetaminophen) | Cerebral edema | 3 | 56 | PSC | No complication | Alive at 12 mo |
UNOS #9[8] | 46 | N/A | N/A | 2 | N/A | N/A | N/A | Alive at 11 mo |
UNOS #10[8] | 25 | N/A | N/A | 2.8 yr | N/A | N/A | N/A | Alive at 5.9 mo |
UNOS #11[8] | 44 | N/A | N/A | 17 | N/A | N/A | N/A | Alive at 3.0 mo |
Barcelona, Spain[9] | 55 | Alcoholic | CVA | 5 | 58 | HCV | No complication | Alive at 120 mo |
Barcelona, Spain[9] | 58 | Alcoholic | CVA | 14 | 55 | Budd Chiari synd | No complication | Alive at 13 mo |
Barcelona, Spain[9] | 58 | Alcoholic | CVA | 10 | 47 | Ischemic cholangitis | AR | Alive at 7 mo |
Creteil, France[10] | 72 | Alcoholic | CVA | 13 yr | 61 | Cryptogenic cirrhosis, | No complication | Alive at 12 mo |
Montreal, Canada[11] | 26 | ALF (acetaminophen overdose) | Cerebral edema | 2 | 62 | Hemochromatosis HCC | No complication | Alive at 30 mo |
Berlin, Germany[12] | 53 | Cryptogenic cirrhosis | Cerebral edema | 24 | 43 | Alcoholic, HCC | Biliary obstruction by stones | Alive at 6 mo |
Stuttgart, Germany[13] | 38 | Budd Chiari synd | CVA | 5 yr | 51 | Polycystic liver disease | No complication | Alive at 18 mo |
Malatya, Turkey[14] | 4 | ALF (hepatitis A) | Cerebral edema | 5 | 31 | Cryptogenic cirrhosis, HCC | HAT at one month, died at 1.3 mo | - |
- Citation: Tanaka H, McAlister VC, Levstik MA, Ghent CN, Marotta PJ, Quan D, Wall WJ. Reuse of liver grafts following the brain death of the initial recipient. World J Hepatol 2014; 6(6): 443-447
- URL: https://www.wjgnet.com/1948-5182/full/v6/i6/443.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i6.443